Alopecia Areata Market by Types (Alopecia Areata (Patchy), Persistent Patchy Alopecia Areata, Alopecia Areata Totalis, Diffuse Alopecia Areata, Alopecia Areata Universalis, Ophiasis Alopecia Areata, and Others), Diagnosis (Skin Biopsy, Trichoscopy, Blood Test, and Others), Treatments (Corticosteroid Drugs, Steroids, Anti-Inflammatory Drugs, Vasodilator, Immunosuppressive Drugs, UV Light Therapy, and Others), Routes of Administration (Topical, Oral, Parenteral, and Others), Distributions Channels (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, and Others), End-users (Specialty Clinics, Hospitals, Homecare, and Others), and Regions (Asia Pacific, North America, Latin America, Europe and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 - 2031
Alopecia Areata Market Outlook 2031:
The global alopecia areata market size was valued at USD 2.96 Billion in 2022 and is projected to reach USD 5.04 Billion by 2031, expanding at a CAGR of 10% during the forecast period 2023 - 2031. The growth of the market is attributed to the rising prevalence of hair loss.
Alopecia areata is a type of alopecia, which refers to an autoimmune disorder, which causes hair fall or hair loss in oval or round shape and in patches. Alopecia areata is unpredictable, where hair can regrow after some bald patches. Conversely, sometimes hair do not grow back and bald patches can expand. Rash, redness, and scarring can appear on the bare spots. Itching, burning, or tingling can be felt in these patches as well.
Alopecia areata primarily affects hair; however, in some cases, it can affect nails as well. Ridges and pits can occur on nails for some people affected by severe hair loss. Anyone can develop alopecia areata; however, individuals related to a person suffering from the disease or other autoimmune disorders such as lupus, diabetes, and thyroid have high chances of contracting alopecia areata.
Alopecia Areata Market Trends, Drivers, Restraints, and Opportunities
- Growing investments in healthcare infrastructure boosts the market.
- Increasing prevalence of alopecia areata across the globe is expected to drive the market during the forecast period.
- Rising awareness regarding alopecia areata is estimated to fuel the market in the coming years.
- Rising cases of autoimmune diseases and fast changing lifestyle spurs the market.
- High cost of alopecia areata treatment is expected to hamper the growth of the market during the forecast period.
- Lack of awareness regarding the diseases in developing countries hinders the growth of the market.
- Increasing number of research and development activities regarding alopecia areata offer growth opportunities to the key market players.
Scope of the Alopecia Areata Report
The report on the global alopecia areata market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Alopecia Areata Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2021 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Types (Alopecia Areata (Patchy), Persistent Patchy Alopecia Areata, Alopecia Areata Totalis, Diffuse Alopecia Areata, Alopecia Areata Universalis, Ophiasis Alopecia Areata, and Others), Diagnosis (Skin Biopsy, Trichoscopy, Blood Test, and Others), Treatments (Corticosteroid Drugs, Steroids, Anti-Inflammatory Drugs, Vasodilator, Immunosuppressive Drugs, UV Light Therapy, and Others), Routes of Administration (Topical, Oral, Parenteral, and Others), Distributions Channels (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, and Others), and End-users (Specialty Clinics, Hospitals, Homecare, and Others) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast |
Key Players Covered in the Report |
Pfizer, Inc.; Bayer AG; Cipla, Inc.; Teva Pharmaceuticals Industries Ltd.; Aclaris Therapeutics, Inc.; Sanofi; Mylan N.V.; Novartis AG; GSK Group of Companies; AbbVie, Inc.; Lupin; Merck KGaA; Sun Pharmaceuticals Industries, Ltd.; AstraZeneca; Eli Lilly and Company; Perrigo Company plc; and Others |
Alopecia Areata Market Segment Insights
Alopecia areata (patchy) segment drives the market
Based on Types, the market is divided into alopecia areata (patchy), persistent patchy alopecia areata, alopecia areata totalis, diffuse alopecia areata, alopecia areata universalis, ophiasis alopecia areata, and others.
The alopecia areata (patchy) segment is expected to boost the market during the forecast period, due to increasing prevalence of individuals suffering from autoimmune disorders. Rapidly changing lifestyle and increasing stress among individuals across the globe are key factors, which aid in the expansion of the market.
Blood test segment boosts the market
In terms of diagnosis, the market is segregated into skin biopsy, trichoscopy, blood test, and others. The blood test segment is projected to drive the market during the forecast period, as doctors can check for medical conditions such as thyroid, immune system problems, hormone, and others that can cause hair loss.
Corticosteroid drugs segment holds a key market share
On the basis of treatments, the market is segmented into corticosteroid drugs, steroids, anti-Inflammatory drugs, vasodilator, immunosuppressive drugs, UV light therapy, and others.
The corticosteroid drugs segment is estimates to fuel the market during the forecast period, due to their lipid-regulating and anti-inflammatory properties. Increasing usage of corticosteroid drugs in clinical trials aids in the expansion of the segment.
Topical segment registers a high CAGR
In terms of routes of administrations, the market is divided into topical, oral, parenteral, and others. The topical segment is estimated to hold a key market share during the forecast period, owing to increasing demand for topical alopecia areata treatments.
The topical treatment solutions such as medicated hair serum, medicated shampoos, gel, and topical ointment are easily available, easy to use, and non-invasive. Increasing research and development activities in topical treatment solutions aid in the expansion of the segment.
Hospital pharmacy segment spurs the market
Based on distribution channels, the market is segregated into hospital pharmacy, online pharmacy, retail pharmacy, and others. The hospital pharmacy segment is estimated to fuel the market during the forecast period, due to easy availability of alopecia areata treatment prescription drugs in hospital pharmacies.
The online pharmacy segment is anticipated to expand in the coming years, owing to growing penetration of internet, increasing usage of smart devices, rising number of online pharmacies, and increasing benefits of purchasing from online pharmacies such as wide range of products, product comparison, door-step delivery, easy payment methods, and others.
Specialty clinic expands rapidly
On the basis of end-users, the market is distributed into specialty clinics, hospitals, homecare, and others. The specialty clinics segment is expected to drive the market during the forecast period, due to growing number of trichologists and dermatologist across the globe.
Increasing awareness regarding alopecia areata and benefits of hair treatment is drawing individuals across the globe to specialty clinics. These factors aid in the expansion of the segment.
North America dominates the market
In terms of regions, the market is segmented into Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. The market in North America is estimated to hold a significant market share during the forecast period, due to increasing research and development activities regarding alopecia areata in the region.
Increasing cases of hair loss, growing expenditure in healthcare sector, rising early phase diagnosis of the disease, and favorable government policies for hair care companies drive the market in the region. The market in Asia pacific is anticipated to register a high CAGR during the forecast period, owing to increasing cases of alopecia areata among young population, rapidly changing lifestyle, and rising awareness regarding alopecia areata in the region.
2. Assumptions and Acronyms Used
3. Research Methodology
4. Alopecia Areata Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Alopecia Areata Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Alopecia Areata Market - Supply Chain
4.5. Global Alopecia Areata Market Forecast
4.5.1. Alopecia Areata Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Alopecia Areata Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Alopecia Areata Market Absolute $ Opportunity
5. Global Alopecia Areata Market Analysis and Forecast by Types
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Types
5.2.2. Y-o-Y Growth Projections by Types
5.3. Alopecia Areata Market Size and Volume Forecast by Types
5.3.1. Alopecia Areata (Patchy)
5.3.2. Persistent Patchy Alopecia Areata
5.3.3. Alopecia Areata Totalis
5.3.4. Diffuse Alopecia Areata Areata
5.3.5. Alopecia Areata Universalis
5.3.6. Ophiasis Alopecia Areata
5.3.7. Others
5.4. Absolute $ Opportunity Assessment by Types
5.5. Market Attractiveness/Growth Potential Analysis by Types
6. Global Alopecia Areata Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Alopecia Areata Market Size and Volume Forecast by End Users
6.3.1. Specialty Clinics
6.3.2. Hospitals
6.3.3. Homecare
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Alopecia Areata Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Alopecia Areata Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Alopecia Areata Demand Share Forecast, 2019-2026
8. North America Alopecia Areata Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Alopecia Areata Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Alopecia Areata Market Size and Volume Forecast by Types
8.4.1. Alopecia Areata (Patchy)
8.4.2. Persistent Patchy Alopecia Areata
8.4.3. Alopecia Areata Totalis
8.4.4. Diffuse Alopecia Areata Areata
8.4.5. Alopecia Areata Universalis
8.4.6. Ophiasis Alopecia Areata
8.4.7. Others
8.5. Basis Point Share (BPS) Analysis by Types
8.6. Y-o-Y Growth Projections by Types
8.7. North America Alopecia Areata Market Size and Volume Forecast by End Users
8.7.1. Specialty Clinics
8.7.2. Hospitals
8.7.3. Homecare
8.7.4. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Alopecia Areata Demand Share Forecast, 2019-2026
9. Latin America Alopecia Areata Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Alopecia Areata Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Alopecia Areata Market Size and Volume Forecast by Types
9.4.1. Alopecia Areata (Patchy)
9.4.2. Persistent Patchy Alopecia Areata
9.4.3. Alopecia Areata Totalis
9.4.4. Diffuse Alopecia Areata Areata
9.4.5. Alopecia Areata Universalis
9.4.6. Ophiasis Alopecia Areata
9.4.7. Others
9.5. Basis Point Share (BPS) Analysis by Types
9.6. Y-o-Y Growth Projections by Types
9.7. Latin America Alopecia Areata Market Size and Volume Forecast by End Users
9.7.1. Specialty Clinics
9.7.2. Hospitals
9.7.3. Homecare
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Alopecia Areata Demand Share Forecast, 2019-2026
10. Europe Alopecia Areata Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Alopecia Areata Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Alopecia Areata Market Size and Volume Forecast by Types
10.4.1. Alopecia Areata (Patchy)
10.4.2. Persistent Patchy Alopecia Areata
10.4.3. Alopecia Areata Totalis
10.4.4. Diffuse Alopecia Areata Areata
10.4.5. Alopecia Areata Universalis
10.4.6. Ophiasis Alopecia Areata
10.4.7. Others
10.5. Basis Point Share (BPS) Analysis by Types
10.6. Y-o-Y Growth Projections by Types
10.7. Europe Alopecia Areata Market Size and Volume Forecast by End Users
10.7.1. Specialty Clinics
10.7.2. Hospitals
10.7.3. Homecare
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Alopecia Areata Demand Share Forecast, 2019-2026
11. Asia Pacific Alopecia Areata Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Alopecia Areata Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Alopecia Areata Market Size and Volume Forecast by Types
11.4.1. Alopecia Areata (Patchy)
11.4.2. Persistent Patchy Alopecia Areata
11.4.3. Alopecia Areata Totalis
11.4.4. Diffuse Alopecia Areata Areata
11.4.5. Alopecia Areata Universalis
11.4.6. Ophiasis Alopecia Areata
11.4.7. Others
11.5. Basis Point Share (BPS) Analysis by Types
11.6. Y-o-Y Growth Projections by Types
11.7. Asia Pacific Alopecia Areata Market Size and Volume Forecast by End Users
11.7.1. Specialty Clinics
11.7.2. Hospitals
11.7.3. Homecare
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Alopecia Areata Demand Share Forecast, 2019-2026
12. Middle East & Africa Alopecia Areata Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Alopecia Areata Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Alopecia Areata Market Size and Volume Forecast by Types
12.4.1. Alopecia Areata (Patchy)
12.4.2. Persistent Patchy Alopecia Areata
12.4.3. Alopecia Areata Totalis
12.4.4. Diffuse Alopecia Areata Areata
12.4.5. Alopecia Areata Universalis
12.4.6. Ophiasis Alopecia Areata
12.4.7. Others
12.5. Basis Point Share (BPS) Analysis by Types
12.6. Y-o-Y Growth Projections by Types
12.7. Middle East & Africa Alopecia Areata Market Size and Volume Forecast by End Users
12.7.1. Specialty Clinics
12.7.2. Hospitals
12.7.3. Homecare
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Alopecia Areata Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Alopecia Areata Market: Market Share Analysis
13.2. Alopecia Areata Distributors and Customers
13.3. Alopecia Areata Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Pfizer, Inc.
13.4.2. Bayer AG
13.4.3. Cipla, Inc.
13.4.4. Teva Pharmaceuticals Industries Ltd.
13.4.5. Aclaris Therapeutics, Inc.
13.4.6. Sanofi
13.4.7. Mylan N.V.
13.4.8. Novartis AG
13.4.9. GSK Group of Companies
13.4.10. AbbVie, Inc.
13.4.11. Lupin